A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

Chronic pain affects millions of individuals, considerably impacting their quality of life and emotional well-being. You may find that it alters your daily activities, leading to frustration and ...

Treating chronic neuropathic pain with spinal cord stimulation may help prevent excess mortality associated with chronic pain, a new study from the University of Eastern Finland and Kuopio University ...

New technology is helping people with paralysis move again, and it doesn't involve surgery, needles or drugs. It's a first-of-its-kind non-invasive spinal cord stimulation therapy, and it's now ...

People considering high frequency 10 kHz spinal cord stimulation want two things: relief that lasts and a clear price they can plan around. HF10 therapy, delivered by the Nevro Senza system, is an FDA ...

MIAMI, Florida (WFOR) — South Florida patients suffering from chronic pain are finding relief through spinal cord stimulation, a therapy that uses targeted electrical signals to block pain from ...

Lauren Pastrana is the co-anchor of CBS4 News weeknights at 5, 6, 7 and 11 p.m. She joined CBS Miami in April 2012 as a reporter. She is an Emmy-nominated, multimedia journalist with experience in ...

Urinary incontinence is a devastating condition affecting over 33 million Americans, according to the National Association for Continence, leading to significant adverse impacts on patients’ mental ...

The suits cite the U.S. Supreme Court’s 2024 decision in Loper Bright Enterprises v. Rainmondo in naming the FDA as a defendant. The lawsuits allege the devices should require pre-market approval ...

Christopher Maher holds a research fellowship funded by the National Health and Medical Research Council. Caitlin Jones does not work for, consult, own shares in or receive funding from any company or ...